価格表

在庫・価格 : 2025年04月30日 11時59分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-MMP-9, Human, Goat-Poly, Biotin
データシート※最新のデータシートでない場合があります
BAF911 RSDアールアンドディー システムズ
R&D Systems, Inc.
50 μg ¥120,000
(未発注)
追加

在庫・価格 : 2025年04月30日 11時59分 現在

Anti-MMP-9, Human, Goat-Poly, Biotin

  • 商品コード:BAF911
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥120,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Tayebjee MH et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am. J. Hypertens. 2
Tayebjee MH et al
2004/01/01
Application: ELISA Development, Sample Type: Plasma (Not Specified) PubMed
2 Tayebjee MH et al. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation. Am. J. Hypertens. 2004 Sep;17(9):770-4
Tayebjee MH et al
2004/01/01
Application: ELISA Development, Sample Type: Plasma (Citrate) PubMed
3 Tayebjee MH et al. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb. Res. 2005
Tayebjee MH et al
2005/01/01
Application: ELISA Development, Sample Type: Plasma (Citrate) PubMed
4 Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
Gonzalez RM et al
2008/01/01
Application: ELISA Microarray Development, Sample Type: Serum PubMed
5 Madsen EL et al. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. Metab. Clin. Exp. 2009 Jul;58(7):946-53
Madsen EL et al
2009/01/01
Application: Luminex Assay Development, Sample Type: Serum PubMed
6 Ohlsson SM et al. Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies. Clin. Exp. Immunol. 2014 Jun;176(3):363-72
Ohlsson SM et al
2014/01/01
Application: ELISA detection, Sample Type: cell supernates PubMed
7 Roy S et al. Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells. J. Biol. Chem. 2017 Jan;292(2):435-445
Roy S et al
2017/01/01
Species: Human, Applications: ELISA detection PubMed
8 Maetzler W et al. GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia. PLoS ONE 2016;11(3):e0149349
Maetzler W et al
2016/01/01
PubMed
9 Tiainen L et al. Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer. Clin. Breast Cancer 2019 Aug;19(4):e522-e533
Tiainen L et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Tayebjee MH et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am. J. Hypertens. 2
    Tayebjee MH et al
    2004/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Tayebjee MH et al. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation. Am. J. Hypertens. 2004 Sep;17(9):770-4
    Tayebjee MH et al
    2004/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Tayebjee MH et al. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb. Res. 2005
    Tayebjee MH et al
    2005/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
    Gonzalez RM et al
    2008/01/01
  • 備考:
    Application: ELISA Microarray Development, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Madsen EL et al. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. Metab. Clin. Exp. 2009 Jul;58(7):946-53
    Madsen EL et al
    2009/01/01
  • 備考:
    Application: Luminex Assay Development, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ohlsson SM et al. Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies. Clin. Exp. Immunol. 2014 Jun;176(3):363-72
    Ohlsson SM et al
    2014/01/01
  • 備考:
    Application: ELISA detection, Sample Type: cell supernates
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Roy S et al. Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells. J. Biol. Chem. 2017 Jan;292(2):435-445
    Roy S et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ELISA detection
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Maetzler W et al. GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia. PLoS ONE 2016;11(3):e0149349
    Maetzler W et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Tiainen L et al. Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer. Clin. Breast Cancer 2019 Aug;19(4):e522-e533
    Tiainen L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed